HANNAH MCCALL: Open Payments
NPI 1376178798 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 45 payments from 15 companies in 2025. Trend: 2023 $512 · 2024 $870 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $125 |
| Lilly USA, LLC | 7 | $124 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 1 | $62 |
| SANOFI-AVENTIS U.S. LLC | 3 | $61 |
| PFIZER INC. | 3 | $61 |
| Esperion Therapeutics, Inc. | 2 | $46 |
| Boston Scientific Corporation | 1 | $38 |
| Amgen Inc. | 2 | $36 |
Products named: JARDIANCE, Rybelsus, MOUNJARO, VOQUEZNA, TZIELD, ELIQUIS, NEXLETOL, Ozempic.
Industry payments across GA — which companies pay providers there.
